Kintara Therapeutics Inc KTRA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
0.15UNCH (UNCH)
Volume
265,654
Close
0.1513quote price arrow down-0.0059 (-3.7532%)
Volume
2,603,264
52 week range
0.08 - 5.98
Loading...
  • Open0.1565
  • Day High0.1624
  • Day Low0.1499
  • Prev Close0.1572
  • 52 Week High5.98
  • 52 Week High Date05/03/23
  • 52 Week Low0.08
  • 52 Week Low Date03/12/24

Key Stats

  • Market Cap5.906M
  • Shares Out39.04M
  • 10 Day Average Volume10.55M
  • Dividend-
  • Dividend Yield-
  • Beta0.47
  • YTD % Change-10.79

KEY STATS

  • Open0.1565
  • Day High0.1624
  • Day Low0.1499
  • Prev Close0.1572
  • 52 Week High5.98
  • 52 Week High Date05/03/23
  • 52 Week Low0.08
  • 52 Week Low Date03/12/24
  • Market Cap5.906M
  • Shares Out39.04M
  • 10 Day Average Volume10.55M
  • Dividend-
  • Dividend Yield-
  • Beta0.47
  • YTD % Change-10.79

RATIOS/PROFITABILITY

  • EPS (TTM)-5.98
  • P/E (TTM)-0.03
  • Fwd P/E (NTM)-0.12
  • EBITDA (TTM)-10.572M
  • ROE (TTM)-1,697.57%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kintara Therapeutics Inc

 

Content From Our Affiliates

Profile

MORE
Kintara Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development and commercialization of new cancer therapies. It is focused on the development of novel cancer therapies for patients with unmet medical needs. Its two candidates include VAL-083 and REM-001. VAL-083 is a novel, validated, deoxyribonucleic acid (DNA)-targeting agent, for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme (GBM) and potentially...
Robert Hoffman CPA
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
Address
9920 Pacific Heights Blvd
Suite 150, Suite 200
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
PRTG
Portage Biotech Inc
0.271+0.0111+4.2709%
BTI
British American Tobacco plc
29.81+0.01+0.03%
AEZS
Aeterna Zentaris Inc
7.84-0.20-2.49%
ATE
EDSA
Edesa Biotech Inc
4.54-0.01-0.33%